Home › Bile Duct Cancer (Cholangiocarcinoma)
Pag-aaral pangklinika para sa Bile Duct Cancer (Cholangiocarcinoma) na nagre-recruit sa U.S.
56 pag-aaral para sa Bile Duct Cancer (Cholangiocarcinoma) ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX13 pag-aaral
- New York City, NY11 pag-aaral
- Boston, MA8 pag-aaral
- Rochester, MN7 pag-aaral
- Arlington, VA7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Chicago, IL7 pag-aaral
- Columbus, OH6 pag-aaral
- Cleveland, OH6 pag-aaral
- Edison, NJ5 pag-aaral
- Queens, NY5 pag-aaral
- Grand Rapids, MI5 pag-aaral
- Nashville, TN5 pag-aaral
- Philadelphia, PA5 pag-aaral
- San Antonio, TX5 pag-aaral
- Tampa, FL5 pag-aaral
- Dallas, TX5 pag-aaral
- Washington, DC5 pag-aaral
- Mountain View, CA5 pag-aaral
- Baldwin Park, CA5 pag-aaral
- Miami, FL5 pag-aaral
- Baltimore, MD5 pag-aaral
- Orange, CA4 pag-aaral
- St. Louis, MO4 pag-aaral
- Durham, NC4 pag-aaral
- Seattle, WA4 pag-aaral
- Detroit, MI4 pag-aaral
- New Haven, CT4 pag-aaral
- West Valley City, UT3 pag-aaral
- Atlanta, GA3 pag-aaral
- Jacksonville, FL3 pag-aaral
- Salt Lake City, UT3 pag-aaral
- Birmingham, AL3 pag-aaral
- Buffalo, NY3 pag-aaral
- San Francisco, CA3 pag-aaral
- Louisville, KY3 pag-aaral
- Santa Monica, CA3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- Arizona3 pag-aaral
- California20 pag-aaral
- Colorado3 pag-aaral
- Connecticut6 pag-aaral
- Florida13 pag-aaral
- Georgia3 pag-aaral
- Illinois8 pag-aaral
- Kentucky4 pag-aaral
- Maryland9 pag-aaral
- Massachusetts10 pag-aaral
- Michigan8 pag-aaral
- Minnesota10 pag-aaral
- Missouri5 pag-aaral
- New Jersey8 pag-aaral
- New York15 pag-aaral
- North Carolina6 pag-aaral
- Ohio10 pag-aaral
- Pennsylvania5 pag-aaral
- Tennessee5 pag-aaral
- Texas15 pag-aaral
- Utah6 pag-aaral
- Virginia10 pag-aaral
- Washington4 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06728410Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT03942328Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 2 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT01915225A Study of PHST001 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04645160PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05286814A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07265674[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07673341Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06302621Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Nagre-recruitPhase 2
Edad 19 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07146646A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06282575Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07780838Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07282912Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07619313Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07486713TCR1188-ABC Cells in KRAS-mutated Cancers
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07594067Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05285358D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT06622057Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.